Inactive Instrument

Zosano Pharma Corp Stock price Nasdaq

Equities

US98979H1032

Biotechnology & Medical Research

Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO 55 18-12-31
Chief Tech/Sci/R&D Officer - 19-01-31
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 71 17-10-03
Director/Board Member 59 21-05-23
Director/Board Member - 21-12-06
More insiders
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company. The Company is focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using its transdermal microneedle system (the System). Its System is designed to facilitate rapid drug absorption into the bloodstream, and to provide an improved pharmacokinetic (PK) profile compared to original dosage forms. The System consists of a three cm square to six cm square array of titanium microneedles approximately 200-350 microns in length, coated with a hydrophilic formulation of drug, mounted on an adhesive patch. It is focused on development of its lead product candidate, M207, a formulation of zolmitriptan, which is used as an acute treatment for migraine. Its zolmitriptan formulation is delivered utilizing its system. M207 is designed to provide rapid absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal (GI) tract.
More about the company
  1. Stock
  2. Equities
  3. Stock Zosano Pharma Corporation
  4. Stock Zosano Pharma Corp - Nasdaq